Completed PHASE1 INTERVENTIONAL NCT00121160

Health SMART (Stress Management and Relaxation Training) to Improve Vaccine Immune Response

Can Stress Management Improve Vaccine Immune Response

Sponsor: Fred Hutchinson Cancer Center

Interventions Cognitive Behavioral Stress Management (CBSM) group intervention

Updated 6 times since 2017 Last updated: Mar 26, 2012 Started: Sep 30, 2005 Primary completion: Jun 30, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00121160, this PHASE1 trial focuses on Psychological Stress and remains completed. Sponsored by Fred Hutchinson Cancer Center, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
May 2022 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — May 2022 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Data source: Fred Hutchinson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States